How large is the Europe clinical trials market in 2025?

The market stands at USD 23.59 billion in 2025 and is on track to reach USD 32.99 billion by 2030. Read More

Which country commands the biggest share of Europe’s clinical trial activity?

Germany leads with an 18.47% share in 2024, supported by strong infrastructure and new legislation that streamlines approvals. Read More

What is driving the shift toward decentralized and hybrid trials?

Pandemic-era lessons, EMA guidance on remote elements, and technology that enables tele-visits and at-home sampling are fueling a 14.1% CAGR for decentralized services. Read More

Why are Phase II studies growing faster than other phases?

Adaptive designs and biomarker-based enrollment let sponsors validate proof-of-concept more efficiently, pushing Phase II activity at a 7.93% CAGR. Read More

Which therapeutic area attracts the most trials in Europe?

Oncology retains top position with 36.23% market share, thanks to immunotherapy and precision-medicine pipelines. Read More

How will the Clinical Trials Regulation impact study start-up?

Mandatory CTIS use from January 2025 enables a single submission for multi-country trials, cutting administrative workload by up to 50%. Read More

Europe Clinical Trials Companies

This report lists the top Europe Clinical Trials companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Europe Clinical Trials industry.